Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration
- PMID: 8858005
Inflammation, A beta deposition, and neurofibrillary tangle formation as correlates of Alzheimer's disease neurodegeneration
Abstract
We evaluated entorhinal cortex and superior frontal gyrus for hallmarks of Alzheimer's disease (AD) pathology, including inflammation, in three patient sets: AD patients, nondemented elderly patients with few or no neurofibrillary tangles (NFTs) and amyloid beta peptide (A beta) deposits, i.e. normal controls (NC), and nondemented elderly patients with profuse entorhinal cortex NFTs and neocortical A beta deposits, i.e. high pathology controls (HPC). Membrane attack complex (C5b-9) immunoreactivity and immune activation of microglia (MHCII expression) were used as general markers for inflammation. Compared to NC patients, AD patients exhibited significant cortical synapse loss, A beta deposition, NFT formation, and inflammation. HPC patients also had significantly elevated A beta deposition and NFT formation, but there was no evidence of synapse loss and little or no evidence of inflammation. Across patients and brain regions the measures of inflammation each accounted for significant percentages of the variance in synaptophysin immunoreactivity and each was more highly correlated with synapse estimates than NFT formation or A beta deposition.
Similar articles
-
Differential damage in the frontal cortex with aging, sporadic and familial Alzheimer's disease.Brain Res Bull. 2009 Oct 28;80(4-5):196-202. doi: 10.1016/j.brainresbull.2009.06.009. Epub 2009 Jun 25. Brain Res Bull. 2009. PMID: 19559767
-
An immunohistochemical study of neurofibrillary tangle formation in post-encephalitic Parkinsonism.Clin Neuropathol. 1996 Jan-Feb;15(1):22-5. Clin Neuropathol. 1996. PMID: 8998852
-
Neuronal and nonneuronal quantitative BACE immunocytochemical expression in the entorhinohippocampal and frontal regions in Alzheimer's disease.Dement Geriatr Cogn Disord. 2005;19(4):171-83. doi: 10.1159/000083496. Epub 2005 Jan 25. Dement Geriatr Cogn Disord. 2005. PMID: 15677864
-
Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?Int Rev Neurobiol. 2007;82:235-46. doi: 10.1016/S0074-7742(07)82012-5. Int Rev Neurobiol. 2007. PMID: 17678964 Review.
-
Inflammation as a pathogenic mechanism in Alzheimer's disease.Arzneimittelforschung. 1995 Mar;45(3A):439-42. Arzneimittelforschung. 1995. PMID: 7763341 Review.
Cited by
-
Genomics and Drug Discovery Strategies: The Role of Natural Compounds and Its Receptor in Alzheimer's Disease.Cureus. 2024 Jan 17;16(1):e52423. doi: 10.7759/cureus.52423. eCollection 2024 Jan. Cureus. 2024. PMID: 38371064 Free PMC article.
-
A bibliometric analysis of international publication trends in brain atrophy research (2008-2023).Front Neurol. 2024 Jan 31;15:1348778. doi: 10.3389/fneur.2024.1348778. eCollection 2024. Front Neurol. 2024. PMID: 38356880 Free PMC article.
-
Causal functional connectivity in Alzheimer's disease computed from time series fMRI data.Front Comput Neurosci. 2023 Dec 19;17:1251301. doi: 10.3389/fncom.2023.1251301. eCollection 2023. Front Comput Neurosci. 2023. PMID: 38169714 Free PMC article.
-
Links between inflammation and immune functioning with cognitive status among older Americans in the Health and Retirement Study.Brain Behav Immun Health. 2022 Nov 13;26:100559. doi: 10.1016/j.bbih.2022.100559. eCollection 2022 Dec. Brain Behav Immun Health. 2022. PMID: 36439057 Free PMC article.
-
Alzheimer's Drug PBT2 Interacts with the Amyloid β 1-42 Peptide Differently than Other 8-Hydroxyquinoline Chelating Drugs.Inorg Chem. 2022 Sep 19;61(37):14626-14640. doi: 10.1021/acs.inorgchem.2c01694. Epub 2022 Sep 8. Inorg Chem. 2022. PMID: 36073854 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical